Researchers in Singapore have conducted a study showing that the messenger RNA- (mRNA) based coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna are highly effective at protecting against symptomatic and severe disease following infection with the rapidly spreading B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The team conducted a multi-center retrospective cohort study of vaccinated and unvaccinated individuals who had been admitted to hospital following infection with the B.1.617.2 variant of concern.
“To our knowledge, we provide the first data characterizing the impact of vaccination on virologic kinetics by the B.1.617.2 variant,” writes Barnaby Young from the National Centre for Infectious Diseases in Singapore and colleagues.
The team found that individuals fully vaccinated with either Pfizer-BioNTech’s BNT162b2 vaccine or Moderna’s mRNA-1273 product were significantly less likely to develop moderate or severe outcomes following B.1.617.2 infection than unvaccinated individuals.
Vaccination was associated with fewer symptoms, lower peak biomarkers of systemic inflammation, and better clinical outcomes. It was also associated with a more rapid decline in viral RNA load and a robust serologic response.
“Vaccination remains a key strategy for control of COVID-19 pandemic,” says Young and colleagues.
A pre-print version of the research paper isa available on the medRxiv* server, while the article undergoes peer review.
Variants of concern pose a threat to vaccination efforts
Phase 3 clinical trials of mRNA-based vaccines have demonstrated efficacies of 92% to 95% in preventing symptomatic and severe disease following SARS-CoV-2 infection.
While the mass rollout of these vaccines has reduced infection and mortality rates in many countries, the emergence of SARS-CoV-2 variants containing mutations in the viral spike protein has led to growing concerns regarding increased transmissibility and resistance to vaccine-induced immunity.
The spike protein is the main structure the virus uses to infect cells and a primary target of binding and neutralizing antibodies following natural infection or vaccination.
While variants of concern such as B.1.1.7 (alpha), B.1.351 (beta), P.1 (gamma), and B.1.617.2 (delta) have all been shown to exhibit increased transmissibility, the B.1.1.7 and B.1.617.2 strains have also been associated with increased disease severity and hospitalization.
Following the emergence of B.1.617.2 in India, this variant rapidly spread to other countries and had become the most frequently sequenced lineage worldwide by the end of June 2021.
The vaccination program in Singapore
The COVID-19 vaccination program began in Singapore on December 30th, 2020. Free vaccination with either the Pfizer-BioNTech or Moderna product was made available to all Singapore residents, beginning with the elderly and those with high-risk occupations such as healthcare workers.
As of July 19th, 2021, more than 6,837,000 vaccine doses had been administered and approximately 2,792,400 individuals had been fully vaccinated.
What did the researchers do?
Young and colleagues conducted a multi-center retrospective cohort study to characterize the clinical, virologic and serologic features of vaccinated adults with breakthrough B.1.617.2 infection. The results were compared with those of unvaccinated patients who also had B.1.617.2 infection.
Participants were recruited between April 1st and June 14th, 2021, across five study sites: the National Centre for Infectious Diseases, Singapore General Hospital, National University Hospital, Changi General Hospital and Sengkang Hospital.
As they grow, solid tumors surround themselves with a thick, hard-to-penetrate wall of molecular defenses. Getting drugs past that barricade is notoriously difficult. Now, scientists at UT Southwestern have developed nanoparticles that can break [...]
In an article recently published in the journal Talanta, researchers demonstrated a new approach to enable the specific detection of biomarkers in human tear by employing an aptamer-based graphene affinity nanosensor. The ability to detect [...]
Selenium (Se) is an essential element found in aquatic feeds that promotes the proper development, wellbeing, and fitness of marine animals. Selenium can be transformed into nanomaterials that are more easily accessible, absorbed, and consumed by [...]
In an article recently published in the journal Nanotechnology, researchers employed a single particle imaging method for fluorescence excitation with moderate intensity to achieve spatial resolution. Here, the semiconductor nanocrystals were accessed, whose emission lifetimes [...]
Grinding is an essential manufacturing process, yet the heat due to friction associated with the process causes damage to the part being processed. Lubrication is used to reduce friction; however, traditional petroleum-based lubricants can [...]
A team of researchers from HSE University, Skoltech, MPGU, and MISIS have developed a nanophotonic-microfluidic sensor whose potential applications include cancer detection, monitoring and treatment response assessment. Today, the device can identify gases and [...]
Researchers have made a scientific breakthrough with the development of ‘nanomachines’ that can kill cancerous cells. The research team headed by Dr Youngdo Jeong from the Center for Advanced Biomolecular Recognition at the Korea Institute of Science and Technology (KIST) has engineered [...]
A novel freeze-dissolving approach has been devised that offers greater efficiency and sustainability compared to the classic freeze-drying process to make superfine powder or nanoparticles. In the research published in the journal ACS Sustainable Chemistry & Engineering, sphere-shaped [...]
Participants wanted for study on the regulation of what future AI-driven nanomedicines should look like
Would you like to help in some research on the regulation of what future AI-driven nanomedicines should look like? If so, researchers at the University of Bristol are looking for volunteers to discuss ethical [...]
In an article recently published in the journal Applied Surface Science, the researchers synthesized green fluorescent carbon dots (G-CDs) from 3,5-diaminobenzoic acid and citric acid. The as-prepared G-CDs were used to target the nucleolus and [...]
Doxorubicin (DOX) is a powerful anti-cancer medication, and efforts have been made to design nanostructures for delivering it to cancerous cells. The nanostructures increase the cytotoxic effects of DOX on cancerous cells, while reducing the negative effects [...]
A team of Brown University researchers has developed a new responsive material that is able to release encapsulated cargo only when pathogenic bacteria are present. The material could be used to make wound dressings [...]
Novel three-drug regimen used to manage life-threatening developments. In April 2021, a 42-year-old man reached out to Brian Hill, MD, PhD, for a second opinion after being diagnosed with hairy cell leukemia following a bone [...]
When the virus hunters landed in the remote African village of Yambuku in 1976, the nuns warned them to stay back. The sisters had cordoned off the area where they were caring for people [...]